trabectedin analogs targeting EWS-FLI1 (Van Andel Institute)

N/A

Report date: 2025/06/11 10:25:51
NME

Base Information

Drug Nametrabectedin analogs targeting EWS-FLI1 (Van Andel Institute)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionEWS-Fli1 protein inhibitors
TargetsEWS-Fli1 protein
Therapy Area/IndicationsSarcoma, Ewing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVan Andel Institute
China Registration ClassN/A

Develop Information

Active CompaniesVan Andel Institute
Inactive CompaniesN/A
Active IndicationsSarcoma, Ewing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A